BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
indegene limited stock

INDEGENE LIMITED Share Price

589.6 -11.05 (-1.83%)
Dec 13 2024 03:30 PM Healthcare NSE: INDGN

INDEGENE LIMITED Share Price Update

As of the latest trading session, INDEGENE LIMITED share price is currently at 589.6, which is down by -11.05 from its previous closing. Today, the stock has fluctuated between 585.05 and 601.50. Over the past year, INDEGENE LIMITED has achieved a return of 3.27 %. In the last month alone, the return has been -8.36 %. Read More...

INDEGENE LIMITED Performance

Day Range

Low585.05 High601.50
589.60

52 Week Range

Low 470.10 High 736.30
589.60

INDEGENE LIMITED Share Price

23693

544172

INDGN

img img img img
No Data Available

Open Price

601.00

Prev. Close

600.65

Volume (Shares)

470202.00

Total traded value

2772.31

Upper Circuit

720.75

Lower Circuit

480.55

Note: The current prices & values are delayed, Login to your account for live updates.

INDEGENE LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 13092.80
PE Ratio (TTM) 90.44
Book Value / Share 74.11
Beta 0.87
ROE 15.77%
EPS (TTM) 6.52
Dividend Yield 0.00%
Net Profit Qtr (Cr) 44.80

INDEGENE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 281.70
Operating Expense 243.10
Net Profit 44.80
Net Profit Margin (%) 15.90
Earnings Per Share (EPS) 1.88
EBITDA 68.80
Effective Tax Rate (%) 26.55
Particulars JUN 2024 (Values in Cr)
Revenue 258.60
Operating Expense 227.20
Net Profit 32.60
Net Profit Margin (%) 12.60
Earnings Per Share (EPS) 1.41
EBITDA 53.20
Effective Tax Rate (%) 27.71
Particulars MAR 2024 (Values in Cr)
Revenue 272.50
Operating Expense 235.20
Net Profit 48.90
Net Profit Margin (%) 17.94
Earnings Per Share (EPS) 2.20
EBITDA 69.50
Effective Tax Rate (%) 19.03
Particulars DEC 2023 (Values in Cr)
Revenue 260.00
Operating Expense 231.20
Net Profit 29.60
Net Profit Margin (%) 11.38
Earnings Per Share (EPS) 1.34
EBITDA 49.00
Effective Tax Rate (%) 27.45
Particulars SEP 2023 (Values in Cr)
Revenue 260.50
Operating Expense 227.10
Net Profit 29.30
Net Profit Margin (%) 11.24
Earnings Per Share (EPS) 1.32
EBITDA 49.40
Effective Tax Rate (%) 25.63
Particulars MAR 2024 (Values in Cr)
Revenue 1045.60
Operating Expense 915.30
Net Profit 137.90
Net Profit Margin (%) 13.18
Earnings Per Share (EPS) 6.22
EBITDA 218.29
Effective Tax Rate (%) 23.64
Particulars MAR 2023 (Values in Cr)
Revenue 1005.70
Operating Expense 865.90
Net Profit 130.20
Net Profit Margin (%) 12.94
Earnings Per Share (EPS) 5.89
EBITDA 214.70
Effective Tax Rate (%) 26.27
Particulars MAR 2022 (Values in Cr)
Revenue 836.70
Operating Expense 694.60
Net Profit 132.70
Net Profit Margin (%) 15.85
Earnings Per Share (EPS) 758.28
EBITDA 196.50
Effective Tax Rate (%) 21.89
Particulars MAR 2021 (Values in Cr)
Revenue 511.00
Operating Expense 381.71
Net Profit 133.39
Net Profit Margin (%) 26.10
Earnings Per Share (EPS) 850.00
EBITDA 177.48
Effective Tax Rate (%) 17.39
Particulars MAR 2020 (Values in Cr)
Revenue 334.50
Operating Expense 265.40
Net Profit 31.69
Net Profit Margin (%) 9.47
Earnings Per Share (EPS) 203.00
EBITDA 57.39
Effective Tax Rate (%) 33.99
Particulars MAR 2024 (Values in Cr)
Book Value / Share 64.37
ROE % 27.01
ROCE % 27.00
Total Debt to Total Equity 0.40
EBITDA Margin 22.56
Particulars MAR 2023 (Values in Cr)
Book Value / Share 48.03
ROE % 29.12
ROCE % 29.51
Total Debt to Total Equity 0.31
EBITDA Margin 19.69
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4352.71
ROE % 34.93
ROCE % 41.60
Total Debt to Total Equity 0.11
EBITDA Margin 18.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2073.47
ROE % 133.87
ROCE % 59.18
Total Debt to Total Equity 0.41
EBITDA Margin 27.01
Particulars MAR 2020 (Values in Cr)
Book Value / Share -668.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.65
EBITDA Margin 22.96
Particulars MAR 2024 (Values in Cr)
Book Value / Share 42.96
ROE % 15.77
ROCE % 19.54
Total Debt to Total Equity 0.05
EBITDA Margin 20.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 35.91
ROE % 18.02
ROCE % 22.85
Total Debt to Total Equity 0.07
EBITDA Margin 21.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3250.00
ROE % 29.36
ROCE % 34.22
Total Debt to Total Equity 0.07
EBITDA Margin 23.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1692.67
ROE % 96.36
ROCE % 47.72
Total Debt to Total Equity 0.12
EBITDA Margin 35.30
Particulars MAR 2020 (Values in Cr)
Book Value / Share -20.67
ROE % 67.47
ROCE % 26.30
Total Debt to Total Equity 0.14
EBITDA Margin 30.22
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 191.00
Total Assets 2545.60
Total Liabilities 2545.60
Total Equity 1429.10
Share Outstanding 222062383
Price to Book Ratio 0.00
Return on Assets (%) 13.22
Return on Capital (%) 18.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 85.80
Total Assets 2203.90
Total Liabilities 2203.90
Total Equity 1063.80
Share Outstanding 221475114
Price to Book Ratio 0.00
Return on Assets (%) 12.07
Return on Capital (%) 18.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 517.30
Total Assets 1353.46
Total Liabilities 1353.46
Total Equity 763.90
Share Outstanding 1754085
Price to Book Ratio 0.00
Return on Assets (%) 12.17
Return on Capital (%) 21.07
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 139.90
Total Assets 596.04
Total Liabilities 596.04
Total Equity 333.08
Share Outstanding 1566965
Price to Book Ratio 0.00
Return on Assets (%) 25.06
Return on Capital (%) 41.75
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 180.34
Total Assets 600.24
Total Liabilities 600.24
Total Equity -15.59
Share Outstanding 1566978
Price to Book Ratio 0.00
Return on Assets (%) -1.04
Return on Capital (%) -1.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 15.60
Total Assets 1220.30
Total Liabilities 1220.30
Total Equity 953.80
Share Outstanding 222062383
Price to Book Ratio 0.00
Return on Assets (%) 11.30
Return on Capital (%) 14.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 54.00
Total Assets 1037.70
Total Liabilities 1037.70
Total Equity 795.30
Share Outstanding 221475114
Price to Book Ratio 0.00
Return on Assets (%) 12.54
Return on Capital (%) 16.37
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 38.80
Total Assets 850.10
Total Liabilities 850.10
Total Equity 650.00
Share Outstanding 1754085
Price to Book Ratio 0.00
Return on Assets (%) 15.60
Return on Capital (%) 20.42
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.20
Total Assets 372.60
Total Liabilities 372.60
Total Equity 253.90
Share Outstanding 1566965
Price to Book Ratio 0.00
Return on Assets (%) 35.53
Return on Capital (%) 52.15
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 36.00
Total Assets 431.10
Total Liabilities 431.10
Total Equity -3.10
Share Outstanding 1566978
Price to Book Ratio 0.00
Return on Assets (%) 7.35
Return on Capital (%) 9.5
Particulars MAR 2024 (Values in Cr)
Net Income 458.60
Cash from Operations 632.60
Cash from Investing -327.20
Cash from Financing -66.20
Net change in Cash 114.30
Free Cash Flow 643.30
Particulars MAR 2023 (Values in Cr)
Net Income 363.00
Cash from Operations 238.40
Cash from Investing -893.30
Cash from Financing 333.10
Net change in Cash -430.00
Free Cash Flow 257.20
Particulars MAR 2022 (Values in Cr)
Net Income 226.49
Cash from Operations 367.38
Cash from Investing -160.20
Cash from Financing 233.47
Net change in Cash 370.31
Free Cash Flow 392.09
Particulars MAR 2021 (Values in Cr)
Net Income 195.84
Cash from Operations 221.64
Cash from Investing -24.24
Cash from Financing -131.50
Net change in Cash 16.27
Free Cash Flow 242.25
Particulars MAR 2020 (Values in Cr)
Net Income 15.12
Cash from Operations 49.25
Cash from Investing -18.49
Cash from Financing 136.35
Net change in Cash 140.13
Free Cash Flow 55.30
Particulars MAR 2024 (Values in Cr)
Net Income 180.60
Cash from Operations 225.50
Cash from Investing -187.70
Cash from Financing -15.80
Net change in Cash -27.30
Free Cash Flow 235.40
Particulars MAR 2023 (Values in Cr)
Net Income 176.60
Cash from Operations 123.70
Cash from Investing -47.90
Cash from Financing -16.90
Net change in Cash 17.10
Free Cash Flow 139.50
Particulars MAR 2022 (Values in Cr)
Net Income 169.90
Cash from Operations 74.10
Cash from Investing -266.70
Cash from Financing 244.90
Net change in Cash 16.40
Free Cash Flow 95.10
Particulars MAR 2021 (Values in Cr)
Net Income 159.90
Cash from Operations 78.90
Cash from Investing -33.20
Cash from Financing -37.10
Net change in Cash -17.00
Free Cash Flow 97.30
Particulars MAR 2020 (Values in Cr)
Net Income 46.50
Cash from Operations 104.60
Cash from Investing -51.40
Cash from Financing -18.50
Net change in Cash 19.70
Free Cash Flow 109.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 88.28 13.93 104442.30 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.05 0.00 3.89 116.29 44.00 / 107.94
SHREE PACETRONIX LTD. 123.75 19.93 3.31 44.54 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.60 0.00 5.31 57.59 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 93.01 12.75 104442.30 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 52.25 0.00 -27.99 39.03 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5501.45 29.84 6.18 6018.59 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 596.70
  • 26 Days 635.40
  • 10 Days 614.20
  • 50 Days 657.30
  • 12 Days 618.80
  • 100 Days 634.80
  • 20 Days 626.30
  • 200 Days 576.50
596.58
PIVOT
First Resistance 609.17
Second Resistance 617.68
Third Resistance 630.27
First Support 588.07
Second Support 575.48
Third Support 566.97
RSI 35.49
MACD -16.60
Commodity Channel Index (CCI) -118.84
ADX 18.14
Williams % R -94.93

Over 1 Month

down

-8.36

Over 3 Months

down

-13.12

Over 6 Months

down

-1.75

Over 1 Year

down

3.27

Over 3 Years

down

0.00

Over 5 Years

down

0.00

INDEGENE LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

INDEGENE LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
92.01
Promoter Holdings
0.0
FII
4.81
DII
3.17
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Nadathur Fareast Pte Ltd Public Shareholding 5.2700256E7 22.03
Ca Dawn Investments Public Shareholding 3.4739187E7 14.52
Manish Gupta Public Shareholding 2.1457076E7 8.97
Rajesh Bhaskaran Nair Public Shareholding 1.7067386E7 7.13
Bpc Genesis Fund I Spv Ltd Public Shareholding 1.5060223E7 6.29
Sanjay S Parikh Public Shareholding 1.1991672E7 5.01
Bpc Genesis Fund I A Spv Ltd Public Shareholding 7811651.0 3.26
Gaurav Kapoor Public Shareholding 6266736.0 2.62
Vida Trustees Private Limited Public Shareholding 5588802.0 2.34
Anand Kiran Public Shareholding 5211360.0 2.18
Aarabhi Partners Consultants Llp Public Shareholding 5040000.0 2.11
Fidelity Funds - India Focus Fund Public Shareholding 3874146.0 1.62
Chestnut Associates (ptc) Limited As Public Shareholding 3439800.0 1.44
Sycamore Associates (ptc) Limited As Public Shareholding 3439800.0 1.44
Smallcap World Fund, Inc Public Shareholding 2503533.0 1.05

INDEGENE LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About INDEGENE LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by INDEGENE LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Indegene Ltd?

Answer Field

The share price of Indegene Ltd for NSE is ₹ 589.6 and for BSE is ₹ 589.7.

What is the Market Cap of Indegene Ltd?

Answer Field

The market cap of Indegene Ltd for NSE is ₹ 1,30,92.80 Cr. and for BSE is ₹ 1,30,95.02 Cr. as of now.

What is the 52 Week High and Low of Indegene Ltd?

Answer Field

The 52 Week High and Low of Indegene Ltd for NSE is ₹ 736.30 and ₹ 470.10 and for BSE is ₹ 736.60 and ₹ 468.90.

How to Buy Indegene Ltd share?

Answer Field

You can trade in Indegene Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indegene Ltd?

Answer Field

The 1 year returns on the stock has been 3.27%.

What is the Current Share Price of Indegene Ltd?

Answer Field

Indegene Ltd share price is for NSE ₹ 589.6 & for BSE ₹ 589.7 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Indegene Ltd Share?

Answer Field

The market cap of Indegene Ltd for NSE ₹ 1,30,92.80 & for BSE ₹ 1,30,95.02 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Indegene Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Indegene Ltd share is 90.44.

What is the PB ratio of Indegene Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Indegene Ltd share is 74.11.

How to Buy Indegene Ltd Share?

Answer Field

You can trade in Indegene Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indegene Ltd Share on Bajaj Broking App?

Answer Field

To buy Indegene Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indegene Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader